| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |